NCT01026753 Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba Status COMPLETED Phase NA
NCT01016639 Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01012804 Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer Status WITHDRAWN Phase N/A
NCT01011478 Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Status TERMINATED Phase PHASE3
NCT01006369 Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01004159 Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan Status TERMINATED Phase PHASE2
NCT00997685 Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC) Status UNKNOWN Phase PHASE2
NCT00995202 Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00991003 A New Method for Colorectal Cancer Screening: Colon Capsule Endoscopy Compared to Conventional Endoscopy Status COMPLETED Phase NA
NCT00986518 T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study Status COMPLETED Phase PHASE1/PHASE2
NCT00986440 Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Status TERMINATED Phase PHASE2
NCT00985400 Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery Status UNKNOWN Phase NA
NCT00984048 Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase N/A